
24/07/2025
In critical care, vibrating mesh nebulizers (VMNs) like AirICU® represent a significant leap forward in non-invasive drug delivery — offering faster treatment times, lower residual volume, and reduced fugitive emissions.
Yet, to fully realise their potential, we must deepen our understanding of drug absorption barriers in ICU settings and invest in large-scale trials to evaluate long-term efficacy and cost-effectiveness.
At AirICU®, we're committed to advancing mesh nebulisation for safer, more effective respiratory and systemic therapies — helping modern medicine harness the full power of pulmonary drug delivery.